CompuGroup Medical SE Performance
| CMPVFDelisted Stock | USD 23.85 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.0836, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning CompuGroup Medical are expected to decrease at a much lower rate. During the bear market, CompuGroup Medical is likely to outperform the market. CompuGroup Medical right now shows a risk of 0.0%. Please confirm CompuGroup Medical standard deviation and skewness , to decide if CompuGroup Medical will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CompuGroup Medical SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, CompuGroup Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 75.9 M | |
| Total Cashflows From Investing Activities | -164 M |
CompuGroup |
CompuGroup Medical Relative Risk vs. Return Landscape
If you would invest 2,385 in CompuGroup Medical SE on October 4, 2025 and sell it today you would earn a total of 0.00 from holding CompuGroup Medical SE or generate 0.0% return on investment over 90 days. CompuGroup Medical SE is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than CompuGroup, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CompuGroup Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuGroup Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CompuGroup Medical SE, and traders can use it to determine the average amount a CompuGroup Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMPVF |
Based on monthly moving average CompuGroup Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CompuGroup Medical by adding CompuGroup Medical to a well-diversified portfolio.
CompuGroup Medical Fundamentals Growth
CompuGroup Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CompuGroup Medical, and CompuGroup Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuGroup Pink Sheet performance.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 20.14 X | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 1.97 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 213.99 M | |||
| Cash And Equivalents | 120.07 M | |||
| Cash Per Share | 2.30 X | |||
| Total Debt | 587.08 M | |||
| Debt To Equity | 1.32 % | |||
| Book Value Per Share | 12.87 X | |||
| Cash Flow From Operations | 165.27 M | |||
| Earnings Per Share | 1.49 X | |||
| Total Asset | 1.79 B | |||
About CompuGroup Medical Performance
By analyzing CompuGroup Medical's fundamental ratios, stakeholders can gain valuable insights into CompuGroup Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CompuGroup Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CompuGroup Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. KGaA was founded in 1987 and is headquartered in Koblenz, Germany. Compugoup Med is traded on OTC Exchange in the United States.Things to note about CompuGroup Medical performance evaluation
Checking the ongoing alerts about CompuGroup Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CompuGroup Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CompuGroup Medical is not yet fully synchronised with the market data | |
| CompuGroup Medical has a very high chance of going through financial distress in the upcoming years | |
| CompuGroup Medical SE has accumulated 587.08 M in total debt with debt to equity ratio (D/E) of 1.32, which is about average as compared to similar companies. CompuGroup Medical has a current ratio of 0.85, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CompuGroup Medical until it has trouble settling it off, either with new capital or with free cash flow. So, CompuGroup Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CompuGroup Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CompuGroup to invest in growth at high rates of return. When we think about CompuGroup Medical's use of debt, we should always consider it together with cash and equity. | |
| About 50.0% of CompuGroup Medical shares are held by company insiders |
- Analyzing CompuGroup Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuGroup Medical's stock is overvalued or undervalued compared to its peers.
- Examining CompuGroup Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CompuGroup Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuGroup Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CompuGroup Medical's pink sheet. These opinions can provide insight into CompuGroup Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in CompuGroup Pink Sheet
If you are still planning to invest in CompuGroup Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CompuGroup Medical's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |